Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-12 Sale |
2024-02-12 4:42 pm |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
60,720 | $0 | $0 | 0 (Direct) |
View |
| 2022-03-03 Purchase |
2022-03-07 4:05 pm |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
5,000 | $59.98 | $299,900 | 10,812 (Direct) |
View |
| 2020-12-24 Sale |
2020-12-28 4:23 pm |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
5,455 | $125 | $681,875 | 3,562 (Direct) |
View |
| 2020-12-18 Sale |
2020-12-22 4:14 pm |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
5,454 | $120 | $654,480 | 9,017 (Direct) |
View |
| 2020-12-11 Sale |
2020-12-15 4:08 pm |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
5,455 | $115 | $627,325 | 14,471 (Direct) |
View |
| 2020-12-01 Sale |
2020-12-03 4:10 pm |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
5,454 | $110 | $599,940 | 19,926 (Direct) |
View |
| 2020-10-19 Sale |
2020-10-21 4:21 pm |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
5,455 | $105 | $572,775 | 3,562 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-12 Option Award |
2024-06-14 5:34 pm |
N/A 2034-06-12 |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
6,812 | $0 | 22,824 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-01 4:30 pm |
N/A 2034-04-30 |
GLYCOMIMETICS INC | GLYC | Goldberg Mark Alan Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-03-29 Option Award |
2024-04-02 4:05 pm |
N/A N/A |
GLYCOMIMETICS INC | GLYC | Goldberg Mark Alan Director |
4,584 | $3 | 36,325 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 5:45 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
569 | $29.65 | 60,720 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-02 4:05 pm |
N/A N/A |
GLYCOMIMETICS INC | GLYC | Goldberg Mark Alan Director |
5,827 | $2.36 | 31,741 (Direct) |
View |
| 2023-10-30 Exercise |
2023-11-01 5:59 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
10,000 | $15.08 | 60,151 (Direct) |
View |
| 2023-10-30 Exercise |
2023-11-01 5:59 pm |
N/A 2023-11-12 |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
10,000 | $0 | 60,151 (Direct) |
View |
| 2023-10-30 Exercise |
2023-11-01 5:59 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
10,000 | $14.7 | 60,151 (Direct) |
View |
| 2023-09-30 Option Award |
2023-10-03 4:15 pm |
N/A N/A |
GLYCOMIMETICS INC | GLYC | Goldberg Mark Alan Director |
9,167 | $1.5 | 25,914 (Direct) |
View |
| 2023-09-29 Option Award |
2023-10-02 5:05 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
1,063 | $15.87 | 60,151 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 5:53 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
894 | $18.87 | 59,088 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 7:06 pm |
N/A 2033-06-21 |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
7,900 | $0 | 21,312 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 4:45 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
32,687 | $0 | 32,687 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-22 4:23 pm |
N/A 2033-05-18 |
GLYCOMIMETICS INC | GLYC | Goldberg Mark Alan Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-03-31 Option Award |
2023-04-04 4:51 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
4,394 | $3.84 | 58,194 (Direct) |
View |
| 2022-12-30 Option Award |
2023-01-04 4:22 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
3,402 | $0 | 160,350 (Direct) |
View |
| 2022-09-30 Option Award |
2022-10-04 4:14 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
3,530 | $0 | 156,948 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 4:36 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
3,750 | $0 | 153,418 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-30 9:55 pm |
N/A 2032-06-21 |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
7,900 | $0 | 18,712 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:31 pm |
2023-06-23 2032-06-23 |
IDERA PHARMACEUTICALS INC. | IDRA | Goldberg Mark Alan Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:22 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
15,000 | $0 | 193,668 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:22 pm |
N/A 2032-06-15 |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
44,000 | $3.37 | 193,668 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 4:08 pm |
N/A 2032-05-17 |
GLYCOMIMETICS INC | GLYC | Goldberg Mark Alan Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2022-03-31 Option Award(A) |
2022-04-20 5:38 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
3,545 | $0 | 134,668 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 4:11 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
3,151 | $0 | 134,274 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 4:02 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
1,819 | $0 | 131,123 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-01 4:14 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
2,380 | $0 | 129,304 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:22 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
2,048 | $0 | 126,924 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:23 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
15,000 | $0 | 168,876 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:23 pm |
N/A 2031-06-16 |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
44,000 | $6.77 | 168,876 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 5:06 pm |
2022-06-08 2031-06-08 |
IDERA PHARMACEUTICALS INC. | IDRA | Goldberg Mark Alan Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 4:21 pm |
N/A 2031-06-02 |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
6,750 | $0 | 10,312 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-27 8:51 pm |
N/A 2031-05-17 |
GLYCOMIMETICS INC | GLYC | Goldberg Mark Alan Director |
15,750 | $0 | 27,247 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 4:30 pm |
N/A N/A |
IDERA PHARMACEUTICALS INC. | IDRA | Goldberg Mark Alan Director |
10,511 | $1.32 | 48,610 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-02 1:02 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
1,666 | $0 | 109,876 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:38 pm |
N/A N/A |
IDERA PHARMACEUTICALS INC. | IDRA | Goldberg Mark Alan Director |
3,452 | $4.02 | 38,099 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-04 10:46 am |
N/A N/A |
ImmunoGen Inc. | IMGN | Goldberg Mark Alan Director |
2,093 | $0 | 108,210 (Direct) |
View |
| 2020-12-24 Exercise |
2020-12-28 4:23 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
5,455 | $28.15 | 3,562 (Direct) |
View |
| 2020-12-24 Exercise |
2020-12-28 4:23 pm |
N/A 2025-06-25 |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
5,455 | $0 | 3,562 (Direct) |
View |
| 2020-12-18 Exercise |
2020-12-22 4:14 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
5,454 | $28.15 | 9,017 (Direct) |
View |
| 2020-12-18 Exercise |
2020-12-22 4:14 pm |
N/A 2025-06-25 |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
5,454 | $0 | 9,017 (Direct) |
View |
| 2020-12-11 Exercise |
2020-12-15 4:08 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
5,455 | $28.15 | 14,471 (Direct) |
View |
| 2020-12-11 Exercise |
2020-12-15 4:08 pm |
N/A 2025-06-25 |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
5,455 | $0 | 14,471 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 4:10 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
5,454 | $28.15 | 19,926 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 4:10 pm |
N/A 2025-06-25 |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
5,454 | $0 | 19,926 (Direct) |
View |
| 2020-10-19 Exercise |
2020-10-21 4:21 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
5,455 | $19.53 | 3,562 (Direct) |
View |
| 2020-10-19 Exercise |
2020-10-21 4:21 pm |
N/A 2026-06-23 |
Blueprint Medicines Corp | BPMC | Goldberg Mark Alan Director |
5,455 | $0 | 3,562 (Direct) |
View |